Aptose Biosciences Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Note 6 - Share Capital (Tables)

9 Months Ended

Sep. 30, 2018

	Three months ended September 30,				Nine months ended September 30,
	2018		2017		2018		2017
Issued common shares, beginning of period		34,411		23,345		27,502		15,722
Effect of ATM issuances		174		716		693		5,180
Effect of shares issued pursuant to share purchase agreements		-		-		3,814		-
Effect of exercise of stock options		2		-		30		-
Effect of RSUs redemptions		-		-		-		52
		34,587		24,061		32,039		20,954